3933 — United Laboratories International Holdings Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapContrarian

Market Cap
HK$19.15bn
Enterprise Value
HK$12.85bn
Revenue
CNY13.21bn

Annual balance sheet for United Laboratories International Holdings, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	HKAS	HKAS	HKAS	HKAS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Cash and Short Term Investments	3,331	4,743	4,262	6,330	10,606
Net Total Accounts Receivable
Net Total Receivables	3,800	4,912	6,314	6,272	4,865
Total Inventory
Total Other Current Assets
Total Current Assets	9,986	12,515	13,787	16,071	18,470
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	6,131	6,266	7,004	9,459	12,076
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	16,331	18,980	21,017	25,833	30,900
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	6,535	7,033	6,627	8,773	10,079
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	6,991	8,372	8,282	11,445	13,508
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	9,340	10,608	12,735	14,388	17,393
Total Liabilities & Shareholders' Equity	16,331	18,980	21,017	25,833	30,900
Total Common Shares Outstanding